Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Characterization of multidrug-resistant extended spectrum β-lactamase producing Escherichia coli from commercial swine farms in Ohaukwu local government Area, Ebonyi State Nigeria

Breadcrumb

  • Home
  • Characterization of Multidrug-resistant Extended Spectrum Β-lactamase Producing Escherichia Coli From Commercial Swine Farms In Ohaukwu Local Government Area, Ebonyi State Nigeria
  • Characterization of multidrug-resistant extended spectrum β-lactamase producing Escherichia coli from commercial swine farms in Ohaukwu local government Area, Ebonyi State Nigeria

Obinna Okpaga Awoke 1, Peter Anyigor Edeh 2, *, Uchechukwu Onyeukwu Ekuma 3, John Ugadu Ede 4, Michael Ali Ituma 5, Ikechukwu Ituma Odo 6, Calista Odinachi Itubochi 2, Juliet Ugama Okpaga 1, Chijioke Ugbala Ekpono 7, Chima Udu Awoke 8 and Ifeanyi Romanus Iroha 1

1 Department of Applied Microbiology, Faculty of Science, Ebonyi State University, Abakaliki, Nigeria.
2 Department of Microbiology, Kingsley Ozumba Mbadiwe University Ideato Imo State Nigeria
3 Department of Microbiology, Federal University of Technology Owerri, Nigeria
4 Department of Biology/Biotechnology, David Nweze Umahi Federal University of Sciences, Uburu Ebonyi State Nigeria
5 Department of Microbiology, Alex Ekwueme Federal University Ndufu-Alike Ikwo, Ebonyi State Nigeria
6 Department of Biology, Alex Ekwueme Federal University Ndufu-Alike Ikwo, Ebonyi State Nigeria
7 Department of Microbiology, David Nweze Umahi Federal University of Sciences, Uburu Ebonyi State Nigeria
8 Department of Industrial Chemistry, Ebonyi State University, Abakaliki Nigeria.
Research Article
GSC Biological and Pharmaceutical Sciences, 2025, 30(02), 306-319.
Article DOI: 10.30574/gscbps.2025.30.2.0062
DOI url: https://doi.org/10.30574/gscbps.2025.30.2.0062
Received on 05 January 2025; revised on 20 February 2025; accepted on 23 February 2025
Background: The expanding use of antimicrobials in livestock is an important contributor to the worldwide rapid increase in antimicrobial resistance (AMR). The transfer of antibiotic resistance to humans, which usually occurs via the food chain, is of concern for human health. This study assessed the incidence of multiple antibiotic resistance of Extended Spectrum β-lactamase producing Escherichia coli isolated from swine in Ohaukwu local government area of Ebonyi State, Nigeria.
Methodology: A total of 400 rectal and nasal swabs samples were randomly collected from four pig farms and analyzed for the presence of ESBL-producing E. coli. Phenotypic detection of ESBL-producing E. coli was done using double disk synergy test (DDST). Antibiotics susceptibility testing of ESBL-producing E. coli was determined against different classes of antibiotics using Kirby–Bauer disk diffusion method and multiple antibiotic resistance index (MARI) was determined.
Results: Out of 400 swine samples collected, sow/piglets have 164(41.0%), the weaners 140(35.0%) while the finishers were 96 representing 24%. Furthermore, it revealed that out of the 400 samples studied, 157 (39.3%) were E. coli positive, rectal had 85 (42.5%) and nasal had 72 (36.0%). Exactly 19 (12.1%) were ESBL-producing E. coli out of the 157 isolates analyzed, 13 (15.3%); 6 (8.3%) were from rectal and nasal swabs respectively. The ESBL-producing E. coli from swine samples showed varying range of resistance to the antibiotic tested. The ESBL-producing E. coli isolates from rectal swab showed high resistant profile to Amoxicillin/Clavulanic acid, (76.9%); Cefepime, (92.3%); Ceftazidime, (84.6%); Nalidixic acid, (92.3%); and Piperacillin/Tazobactam and Cefoxitin, (100.0%). The ESBL-producing E. coli isolates from nasal swabs were (100.0%) resistance to Amoxicillin/Clavulanic acid, Cefepime, Cefoxitin, Colistin, Nalidixic acid and were (100.0%) susceptible to meropenem. The multi antibiotic resistance index of the isolates ranged from 0.33 to 0.83 with average index of 0.66.
Conclusion: The ESBL-producing E. coli isolates from swine was at high prevalence. This therefore is a big threat to public health and calls for a strict measure in the choice of antibiotics used in swine productions
ESBL; E. Coli; Multi Antibiotic Resistance; Swine; Ohaukwu; Ebonyi
 
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2025-…

Preview Article PDF

Obinna Okpaga Awoke, Peter Anyigor Edeh, Uchechukwu Onyeukwu Ekuma, John Ugadu Ede, Michael Ali Ituma, Ikechukwu Ituma Odo, Calista Odinachi Itubochi, Juliet Ugama Okpaga, Chijioke Ugbala Ekpono, Chima Udu Awoke and Ifeanyi Romanus Iroha. Characterization of multidrug-resistant extended spectrum β-lactamase producing Escherichia coli from commercial swine farms in Ohaukwu local government Area, Ebonyi State Nigeria. GSC Biological and Pharmaceutical Sciences, 2025, 30(2), 306-319. Article DOI: https://doi.org/10.30574/gscbps.2025.30.2.0062


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution